Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vestergaard

Showing results (131-140 of 520) with videos related to

Pageof 52
Sort By:
Current Drug Safety|April 20, 2023
Association between Glucose-lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort StudyJakob Hasselstrøm Jensen, Peter Vestergaard, Morten Hasselstrøm Jensen
Clinical Endocrinology|November 3, 2010
Determinants of plasma PTH and their implication for defining a reference intervalLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 2, 2008
Intake of vitamin D and risk of breast cancer--a meta-analysisTina Gissel, Lars Rejnmark, Leif Mosekilde, et al.
Calcified Tissue International|December 25, 2010
Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up studyLars Rejnmark, Peter Vestergaard, Christine Brot, et al.
JBMR Plus|November 29, 2023
Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes-A Systematic ReviewRikke Viggers, Nicklas Højgaard-Hessellund Rasmussen, Peter Vestergaard
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 2, 2017
Phosphate Kinetic Models in Hemodialysis: A Systematic ReviewSisse H Laursen, Peter Vestergaard, Ole K Hejlesen
Magma (New York, N.Y.)|July 11, 2006
The impact of susceptibility gradients on cartesian and spiral EPI for BOLD fMRIRyan Sangill, Mikkel Wallentin, Leif Østergaard, et al.
World Journal of Surgery|May 8, 2007
Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?Peter Vestergaard, Else Marie Vestergaard, Helle Brockstedt, et al.
Pageof 52

Showing results (131-140 of 520) with videos related to

Sort By:
Pageof 52
Current Drug Safety|April 20, 2023
Association between Glucose-lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort StudyJakob Hasselstrøm Jensen, Peter Vestergaard, Morten Hasselstrøm Jensen
Clinical Endocrinology|November 3, 2010
Determinants of plasma PTH and their implication for defining a reference intervalLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 2, 2008
Intake of vitamin D and risk of breast cancer--a meta-analysisTina Gissel, Lars Rejnmark, Leif Mosekilde, et al.
Calcified Tissue International|December 25, 2010
Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up studyLars Rejnmark, Peter Vestergaard, Christine Brot, et al.
JBMR Plus|November 29, 2023
Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes-A Systematic ReviewRikke Viggers, Nicklas Højgaard-Hessellund Rasmussen, Peter Vestergaard
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 2, 2017
Phosphate Kinetic Models in Hemodialysis: A Systematic ReviewSisse H Laursen, Peter Vestergaard, Ole K Hejlesen
Magma (New York, N.Y.)|July 11, 2006
The impact of susceptibility gradients on cartesian and spiral EPI for BOLD fMRIRyan Sangill, Mikkel Wallentin, Leif Østergaard, et al.
World Journal of Surgery|May 8, 2007
Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?Peter Vestergaard, Else Marie Vestergaard, Helle Brockstedt, et al.
Pageof 52